Early Access Program (EAP) Experience of Pritelivir in the Treatment of Acyclovir- and Foscarnet-Refractory Herpes Simplex Virus (HSV) Infection in Immunocompromised (IC) Patients (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 13; Pres time: Oct 22, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available
Clinical • Herpes Simplex • Infectious Disease
|
|
Yeon Joo Lee, MD, MPH; Robin K. Avery, MD, FIDSA; Jana K. Dickter, MD (she/her/hers); Sanjeet S. Dadwal, MD (he/him/his); Dionysios Neofytos, MD; Stuart Cohen, MD; Whitney Perry, MD; Gowri Satyanarayana, MD; Melanie E. Sumner, MSc; Dilruwan C Herath, MD; Alessandra Marini, MD; Alexander Birkmann, PhD (he/him/his); Cynthia Wat, MBBS MRCP MFPM; Kirthana Beaulac, PharmD; Genovefa Papanicolaou, MD
|